1 V Verily
$3B Jan 26, 2017 Series B+
Mar 19, 2026 · $300M Series B+
2 C Cyera
$2.7B Mar 29, 2022 · $60M Series A
Sep 22, 2026 · $400M Series B+
3 D Devoted Health
$2.27B Oct 23, 2017 · $62M Series A
Mar 26, 2026 · $366M Series B+
4 Z Zipline
$1.57B May 17, 2019 · $190M Series B+
Mar 23, 2026 · $200M Series B+
5 C CMR Surgical
$1.41B Sep 17, 2019 · $242.09M Series B+
Oct 12, 2026 · $400M Series B+
6 A Alan
$1.39B Apr 9, 2018 · $28.3M Series A
Jun 25, 2026 · $544.42M Series B+
7 O Oura
$1.24B Nov 29, 2016 · $5.3M Series A
Jul 15, 2026 Series B+
8 N Neko
$1.02B Jul 5, 2023 · $65M Series A
Jul 15, 2026 · $700M Series B+
9 O OpenEvidence
$985M Feb 20, 2025 · $75M Series A
Sep 24, 2026 · $250M Series B+
10 U Uniphore
$885.5M May 7, 2015 Series A
Apr 8, 2026 Series B+
11 L Lambda
$859M Jul 1, 2021 · $15M Series A
Nov 18, 2025 Series B+
12 E Element Biosciences
$823M Jun 18, 2019 · $15M Series A
Jun 9, 2026 · $175M Series B+
13 L Lightmatter
$800M Feb 5, 2018 · $11M Series A
Oct 21, 2024 · $400M Series B+
14 W WHOOP
$773M Jun 24, 2014 · $6M Series A
Jun 5, 2026 · $575M Series B+
15 T Tipalti
$739M Oct 27, 2014 · $13M Series B+
Sep 24, 2025 · $200M round
16 B Beeline Medicines
$726.3M Apr 16, 2026 · $300M Series A
Jul 6, 2026 · $426.3M Series A
17 E Enveda
$714M Dec 21, 2022 · $68M Series B+
Sep 23, 2026 · $311M Series B+
18 E EliseAI
$710M Jun 7, 2023 · $35M Series B+
Sep 29, 2026 · $350M Series B+
19 L Lila Sciences
$700M Sep 15, 2025 · $350M Series A
Jun 4, 2026 · $350M Series A
20 S Strive Health
$690M Apr 1, 2019 · $80M Series A
Sep 9, 2025 · $300M Series B+
21 N NewLimit
$650M May 16, 2023 · $40M Series A
Jun 2, 2026 · $435M Series B+
22 M Mirador Therapeutics
$650M Mar 21, 2024 · $400M Series A
Jan 13, 2026 · $250M Series B+
23 S Solugen
$643.4M Oct 24, 2017 · $4.4M seed
Mar 17, 2026 · $50M Series B+
24 M Medable
$633M May 4, 2020 · $25M Series A
Mar 25, 2026 · $304M Series B+
25 S Synchron
$600M Apr 4, 2017 · $10M Series A
Jun 29, 2026 · $275M Series B+
26 T Tonal
$580M Oct 1, 2015 · $3M seed
Apr 10, 2023 · $130M round
27 V VulcanForms
$575M Jul 5, 2022 · $355M Series B+
Jan 30, 2026 · $220M Series B+
28 T Tubulis
$573M Jul 1, 2020 · $12M Series A
Oct 16, 2025 · $360M Series B+
29 L LifeMine Therapeutics
$543M Sep 18, 2017 · $55M Series A
Aug 6, 2026 · $188M Series B+
30 G Gong
$541M Jun 1, 2016 · $6M seed
Oct 14, 2025 Series B+
31 V Varda
$528M Apr 5, 2024 · $90M Series B+
Sep 30, 2026 · $251M Series B+
32 S Skyryse
$513M Dec 17, 2019 · $13M Series B+
Feb 3, 2026 · $300M Series B+
33 S SiMa AI
$495M May 12, 2020 · $30M Series A
Sep 28, 2026 · $150M Series B+
34 E Exein
$494.12M Nov 8, 2018 · $2.28M seed
Sep 15, 2026 · $270M Series B+
35 A Abcuro
$463M Nov 9, 2018 Series A
Aug 18, 2026 · $66M Series B+
36 T Treeline Biosciences
$461M Oct 17, 2022 · $261M Series A
Sep 3, 2025 · $200M Series A
37 S Synthego
$459M Jul 1, 2013 · $8M Series A
Feb 17, 2022 · $200M Series B+
38 B Biofourmis
$456M Aug 11, 2016 · $1M pre seed
Jul 27, 2022 · $20M Series B+
39 O Orca Bio
$442M Jun 17, 2020 · $192M Series B+
Apr 29, 2026 Series B+
40 A AdvanCell
$439.5M Aug 24, 2022 · $12.5M Series B+
Jul 15, 2026 · $315M Series B+
41 H Horizon3.ai
$428.5M Jun 8, 2021 · $8.5M Series A
Aug 3, 2026 · $250M Series B+
42 A Acko
$426M May 23, 2017 · $30M seed
Oct 28, 2021 · $255M Series B+
43 O OMass Therapeutics
$422.51M Feb 17, 2020 Series A
Oct 15, 2026 · $310M Series B+
44 D Dren Bio
$415M Oct 16, 2020 Series A
Oct 29, 2026 · $350M round
45 S Star Therapeutics
$415M Sep 5, 2023 · $90M Series B+
Oct 23, 2026 · $200M Series B+
46 T Torl Bio
$412M Apr 13, 2023 · $158M Series B+
Oct 7, 2025 · $96M Series B+
47 V Verdiva Bio
$410M Jan 9, 2025 · $410M Series A
—
48 P Plenty
$405M Jan 25, 2022 · $400M Series B+
May 1, 2024 · $5M seed
49 D Distalmotion
$390M Aug 21, 2013 Series A
Nov 18, 2025 · $150M Series B+
50 H Hippocratic AI
$385M May 16, 2023 · $50M seed
Nov 3, 2025 · $126M Series B+
51 T Transcarent
$384M Jun 9, 2021 · $58M Series B+
May 2, 2024 · $126M Series B+
52 C Colossal
$380M Mar 9, 2022 · $60M Series A
Sep 18, 2025 · $120M Series B+
53 A Aidoc
$373M Apr 17, 2019 · $27M Series B+
Apr 29, 2026 · $150M Series B+
54 F Formation Bio
$372M Jun 26, 2024 · $372M Series B+
—
55 H Hostaway
$365M Nov 19, 2018 seed
Dec 17, 2024 · $365M round
56 U Umoja Biopharma
$363M Nov 1, 2020 · $53M Series A
Jan 14, 2025 · $100M Series B+
57 M Musely
$360M Mar 25, 2026 Series B+
May 2, 2026 · $360M round
58 T Talkiatry
$360M Jul 29, 2021 · $20M Series A
Feb 12, 2026 · $210M Series B+
59 C Cellares
$357M Oct 1, 2020 · $18M Series A
Jul 16, 2026 Series B+
60 F Function Health
$351M Jun 26, 2024 · $53M Series A
Nov 19, 2025 · $298M Series B+
61 C CellCentric
$340M May 19, 2025 · $120M Series B+
May 6, 2026 · $220M Series B+
62 A Aspen Neuroscience
$339M Dec 12, 2019 · $6.5M seed
Nov 20, 2025 · $115M Series B+
63 S Soufflé Therapeutics
$335M Oct 13, 2025 · $200M Series A
Oct 13, 2026 · $135M Series B+
64 H Halter
$334M Apr 27, 2021 · $29M Series B+
Jun 29, 2026 Series B+
65 G Grow Therapy
$328M Sep 23, 2021 · $15M Series A
Mar 3, 2026 · $150M Series B+
66 M MMI
$310M Jul 21, 2022 · $75M Series B+
Oct 8, 2026 · $125M Series B+
67 P Precision Neuroscience
$303M May 25, 2021 · $12M Series A
Sep 24, 2026 · $250M Series B+
68 B Blueground
$302M Jan 1, 2016 · $2M seed
Mar 28, 2024 · $45M Series B+
69 H Headway
$295M May 4, 2021 · $70M Series B+
Jul 23, 2024 · $100M Series B+
70 I Immunai
$295M May 14, 2020 · $20M seed
Oct 28, 2021 · $215M Series B+
71 A Amolyt Pharma
$294M Jul 1, 2019 · $74M Series A
Jan 6, 2023 · $140M Series B+
72 S Synthekine
$290M Sep 1, 2020 · $82M Series A
Jan 6, 2023 · $100M Series B+
73 A Arbor Biotechnologies
$289M Nov 9, 2021 · $215M Series B+
Mar 18, 2025 · $74M Series B+
74 A AltruBio
$288M Apr 15, 2021 · $63M Series A
May 21, 2024 · $225M Series B+
75 A Airalo
$285.4M Oct 11, 2021 · $5.4M Series A
Jul 10, 2025 · $220M Series B+
76 E Emalex Biosciences
$285M Mar 23, 2021 · $35M Series B+
Nov 3, 2022 · $250M Series B+
77 T T-Therapeutics
$283M Nov 15, 2023 · $59M Series A
Nov 5, 2026 · $133M Series B+
78 E Eight Sleep
$276M Nov 6, 2019 · $40M Series B+
Mar 4, 2026 · $50M round
79 D Dexory
$275.31M Jun 27, 2023 · $19M Series A
Apr 7, 2026 · $11.31M Series B+
80 A Abnormal Security
$274M Nov 1, 2019 · $24M Series A
Mar 6, 2026 Series B+
81 S Scandit
$273.5M Mar 25, 2014 · $5.5M pre seed
Feb 9, 2022 · $150M Series B+
82 S Staffbase
$272.25M May 31, 2016 · $2.25M Series A
Mar 14, 2022 · $115M Series B+
83 A A2 Biotherapeutics
$270.5M Nov 5, 2019 · $57M Series A
Jan 10, 2025 · $80M Series B+
84 O Orbital Therapeutics
$270M Apr 26, 2023 · $270M Series A
Aug 3, 2025 Series A
85 N Nouscom
$267.56M May 17, 2016 · $13.58M Series A
Oct 19, 2026 · $135.04M Series B+
86 G Garner Health
$263M Dec 14, 2021 · $45M Series B+
May 28, 2026 · $100M Series B+
87 C Cardurion Pharmaceuticals
$260M Jul 16, 2024 · $260M Series B+
—
88 C CatalYm
$259.04M Nov 10, 2020 · $59.04M Series B+
Jul 16, 2024 · $150M Series B+
89 A Acepodia
$256M Mar 16, 2021 · $47M Series B+
Jun 7, 2023 · $100M Series B+
90 C Canary Technologies
$255M Feb 24, 2022 · $15M Series A
Jul 6, 2026 · $80M Series B+
91 M Matchpoint Therapeutics
$250M Oct 17, 2022 · $100M Series A
Oct 7, 2026 · $150M Series B+
92 F Forge Biologics
$250M Jul 21, 2020 · $40M Series A
Sep 12, 2022 · $90M Series B+
93 M Midi Health
$249M Oct 27, 2022 · $14M seed
Mar 17, 2026 · $100M Series B+
94 H Huma Therapeutics
$248M May 12, 2021 · $130M Series B+
Sep 11, 2024 · $38M round
95 A ARTBIO
$245M Jul 28, 2023 · $23M seed
Jul 29, 2025 · $132M Series B+
96 A Aiolos Bio
$245M Nov 20, 2023 · $245M Series A
—
97 S ShiftMed
$245M Oct 27, 2021 · $45M Series B+
Feb 6, 2023 · $200M round
98 C Cloudbeds
$244M Jul 1, 2016 · $3M Series A
Nov 3, 2021 · $150M Series B+
99 I IDRx
$242M Aug 2, 2022 · $122M Series A
Aug 8, 2024 · $120M Series B+
100 V Viz.ai
$242M Jul 18, 2018 · $21M Series A
Apr 7, 2022 · $100M Series B+
101 T Tissium
$241.14M Mar 1, 2016 · $25M Series A
Jun 23, 2026 · $60M Series B+
102 P Pathos
$237M Oct 23, 2026 · $237M Series B+
—
103 M MOMA Therapeutics
$236M Apr 14, 2020 · $86M Series A
May 10, 2022 · $150M Series B+
104 F Frontier Medicines
$235.5M Jun 25, 2019 · $67M Series A
Aug 28, 2025 Series B+
105 T Tenpoint Therapeutics
$235M Jan 29, 2026 · $235M Series B+
Jun 12, 2026 Series A
106 O Oricell Therapeutics
$235M Jul 1, 2022 · $120M Series B+
Apr 10, 2026 round
107 C City Therapeutics
$234.5M Oct 8, 2024 · $135M Series A
Aug 8, 2026 Series B+
108 C Chai Discovery
$230M Sep 1, 2024 · $30M seed
Jul 14, 2026 round
109 S Science
$230M Mar 5, 2026 · $230M Series B+
—
110 A Arthrosi Therapeutics
$228M Jul 12, 2023 · $75M Series B+
Oct 8, 2025 · $153M Series B+
111 A Apollo Therapeutics
$226.5M Sep 6, 2023 · $226.5M Series B+
—
112 D Domino Data Lab
$223.5M Aug 1, 2015 · $3M Series A
Oct 14, 2025 Series B+
113 E Engrail Therapeutics
$221M Jun 18, 2020 · $32M Series A
Mar 19, 2024 · $157M Series B+
114 A Atavistik Bio
$220M Aug 24, 2021 · $60M Series A
Mar 5, 2026 · $40M Series B+
115 P Papa
$220M Oct 9, 2019 · $10M Series A
Apr 25, 2025 Series B+
116 E Elemy
$219M Oct 8, 2021 · $219M Series B+
—
117 A Asher Bio
$218M Mar 23, 2021 · $55M Series A
Apr 16, 2024 · $55M Series B+
118 T Third Arc Bio
$217M Jul 22, 2024 · $165M Series A
Feb 4, 2026 · $52M Series A
119 I Immuta
$217M Jun 1, 2017 · $7M Series A
Aug 5, 2025 Series B+
120 G Geneoscopy
$216.9M Oct 2, 2019 · $6.9M Series A
Jan 8, 2025 · $105M Series B+
121 W Warp Sciences
$215M Oct 22, 2026 · $215M Series A
—
122 T Tune Therapeutics
$215M Dec 2, 2021 · $40M Series A
Jan 12, 2025 · $175M Series B+
123 H HI-Bio
$215M Nov 1, 2022 · $120M Series A
Jan 4, 2024 · $95M Series B+
124 B Biolinq
$214.75M Nov 27, 2017 · $10M Series A
Apr 22, 2025 · $100M Series B+
125 W Wheel
$213.9M Jan 28, 2020 · $13.9M Series A
May 5, 2025 Series B+
126 I Immune-Onc Therapeutics
$211M Sep 6, 2016 · $7M Series A
Jan 5, 2023 · $131M Series B+
127 H HotSpot Therapeutics
$210M Jul 17, 2018 · $45M Series A
Nov 29, 2021 · $100M Series B+
128 C Chapter
$209M Sep 21, 2021 · $17M Series A
Apr 9, 2026 · $100M Series B+
129 J Jnana Therapeutics
$207M Dec 14, 2017 · $50M Series A
Nov 15, 2022 · $107M Series B+
130 Y YuLife
$207M Nov 1, 2018 · $4M seed
Aug 2, 2022 · $120M Series B+
131 I Inspiren
$205M Mar 20, 2025 · $35M Series A
Sep 10, 2026 · $70M Series B+
132 D Draig Therapeutics
$205M Jun 18, 2025 · $140M seed
Jul 14, 2026 · $65M Series B+
133 P Pearl Health
$203M Sep 15, 2021 · $18M Series A
Jul 8, 2026 · $110M Series B+
134 V Verana Health
$202M Jan 14, 2022 · $150M Series B+
Apr 30, 2026 Series B+
135 A Amber Therapeutics
$200M Jun 10, 2024 · $100M Series A
Jul 24, 2026 · $100M Series A
136 W Windward Bio
$200M Jan 10, 2025 · $200M Series A
May 5, 2026 round
137 A AirNexis Therapeutics
$200M Jan 9, 2026 · $200M Series A
—
138 S Sironax
$200M Aug 2, 2022 · $200M Series B+
Sep 4, 2025 Series B+
139 W When I Work
$200M Nov 1, 2021 · $200M Series B+
—
140 N Neuron23
$197M Mar 30, 2022 · $100M Series B+
Jun 24, 2025 · $97M Series B+
141 S Splice Bio
$197M Feb 1, 2022 · $57M Series A
Jun 11, 2025 · $140M Series B+
142 L Laza Medical
$196M Dec 12, 2023 · $36M Series A
Nov 4, 2026 · $160M Series B+
143 A Angle Health
$196M Jul 21, 2020 · $4M seed
Sep 18, 2026 Series B+
144 G Glycomine
$195M Nov 16, 2016 · $12M Series A
May 9, 2025 · $115M Series B+
145 L Liquid Death
$194M Jan 1, 2019 · $2M seed
Jan 4, 2026 seed
146 C Centivo
$194M Jul 18, 2018 · $34M Series A
Sep 24, 2024 · $75M round
147 N NEURA Robotics
$192M Jul 1, 2023 · $56M Series A
Jun 11, 2026 Series B+
148 P Prenuvo
$190M Oct 18, 2022 · $70M Series A
Jul 13, 2026 Series B+
149 Z Zoovu
$188M Dec 1, 2016 · $5M Series A
Jun 15, 2022 · $169M Series B+
150 T T-Knife
$188M Aug 6, 2020 · $78M Series A
Aug 2, 2021 · $110M Series B+
151 T Thatch
$186M Sep 5, 2024 · $38M Series A
Sep 15, 2026 · $108M Series B+
152 H HealthKart
$185.99M Mar 25, 2013 · $14M Series B+
Dec 5, 2022 · $135M Series B+
153 A AvantStay
$185M Sep 1, 2018 · $5M seed
Jul 13, 2026 Series B+
154 Q Qventus
$185M May 14, 2018 · $30M Series B+
Jan 13, 2025 · $105M Series B+
155 F Fore Biotherapeutics
$182.4M Aug 23, 2023 · $75M Series B+
Jul 8, 2026 · $67.4M Series B+
156 N NexHealth
$181.5M Oct 20, 2016 · $1.5M seed
Apr 1, 2022 · $130M Series B+
157 M Mediar Therapeutics
$181M Mar 15, 2023 · $105M Series A
Jan 7, 2026 · $76M Series B+
158 C Celea Therapeutics
$180M Jul 2, 2026 · $180M Series A
—
159 L LogicSource
$180M Apr 7, 2022 · $180M Series B+
—
160 G GlycoEra
$179M Nov 5, 2021 · $49M Series A
May 27, 2025 · $130M Series B+
161 A Accent Therapeutics
$178M May 18, 2018 · $40M Series A
Jan 23, 2024 · $75M Series B+
162 A Azafaros
$177M Feb 1, 2020 · $27M Series A
May 13, 2025 · $150M Series B+
163 C Claris Bio
$175M Jan 5, 2024 · $57M Series A
Jul 28, 2026 · $118M Series B+
164 H HealthifyMe
$175M May 9, 2016 · $6M Series A
Oct 25, 2024 · $45M Series B+
165 A Alpha-9 Oncology
$175M Oct 23, 2024 · $175M Series B+
—
166 M Mariana Oncology
$175M Sep 7, 2023 · $175M Series B+
—
167 P Pulmocide
$174.4M Mar 20, 2017 · $30.4M Series B+
Dec 6, 2022 · $52M Series B+
168 C Candid Health
$172.5M Sep 11, 2024 Series B+
Jul 22, 2026 · $120M Series B+
169 N Noema Pharma
$171M Dec 1, 2020 · $59M Series A
Nov 4, 2025 Series B+
170 A Atomwise
$171M Jun 1, 2015 · $6M seed
Mar 18, 2025 Series B+
171 E Envoy
$171M Jun 1, 2015 · $15M Series A
Jan 11, 2022 · $110M Series B+
172 S Stedi
$170M Aug 18, 2020 · $50M Series B+
Mar 24, 2026 · $50M Series B+
173 F Flare Therapeutics
$167M May 13, 2021 · $82M Series A
Jun 30, 2026 · $85M Series B+
174 L Loyal
$167M Mar 21, 2024 · $45M Series B+
Mar 25, 2026 Series A
175 V Vedanta Biosciences
$166.5M Jul 21, 2021 Series B+
Aug 6, 2026 · $60M round
176 B Bionyra
$165M Jun 22, 2026 · $165M Series A
—
177 S Syremis Therapeutics
$165M Dec 18, 2025 · $165M Series A
—
178 E Excelsior Sciences
$165M Dec 3, 2025 · $95M round
Dec 3, 2025 · $70M Series A
179 E Everside Health
$164M Jul 25, 2022 · $164M round
—
180 B Beewise
$162M Jul 14, 2020 · $10M Series A
Jun 9, 2025 · $50M Series B+
181 P Plate IQ
$160M Nov 4, 2021 · $160M Series B+
—
182 T Tandem Health
$159.5M Jun 19, 2024 · $9.5M seed
Sep 14, 2026 · $100M Series B+
183 A Ablative Solutions
$159.3M Jun 19, 2012 · $5.3M Series A
Jun 13, 2022 · $77M Series B+
184 A AKUR8
$158.9M Mar 11, 2020 · $8.9M Series A
Sep 16, 2024 · $120M Series B+
185 R R1 Therapeutics
$158M Mar 17, 2026 · $77.5M Series A
Sep 30, 2026 · $80.5M Series A
186 E Epicrispr Biotechnologies
$158M Mar 26, 2025 · $68M Series B+
Aug 11, 2026 · $90M Series B+
187 C Crossbow Therapeutics
$157M Jul 11, 2023 · $80M Series A
Mar 26, 2026 · $77M Series B+
188 B Biossil
$156.7M Apr 20, 2026 · $3.7M seed
Sep 28, 2026 · $153M round
189 T Tennr
$156.5M* Mar 26, 2024 · $18M Series A
Jan 6, 2026 Series B+
190 T TrialSpark
$156M Oct 1, 2021 · $156M Series B+
—
191 I Impress
$155.89M Oct 13, 2020 · $5.89M seed
Jul 11, 2022 · $100M Series B+
192 U Ultrahuman
$155.82M Aug 17, 2021 · $17.5M Series B+
Jul 15, 2026 · $60M Series B+
193 T Truemeds
$155.11M Jun 7, 2021 · $5M Series A
Aug 11, 2025 · $85M round
194 Q Qualified Health
$155M Jan 8, 2025 · $30M seed
Mar 25, 2026 · $125M Series B+
195 R Rad AI
$155M Nov 25, 2019 · $4M seed
May 1, 2025 · $8M Series B+
196 A Anaveon
$155M Feb 1, 2019 · $35M Series A
Dec 16, 2021 · $120M Series B+
197 A Antheia
$153M Jun 30, 2021 · $73M Series B+
Jan 27, 2026 · $24M Series B+
198 V Vaderis Therapeutics
$152M Aug 11, 2026 · $152M Series B+
—
199 A Alteogen
$150M Oct 6, 2026 · $150M Series B+
—
200 C Cohere Health
$150M Jul 16, 2020 · $10M Series A
May 17, 2026 Series B+
201 Z Zarminali Pediatrics
$150M Nov 20, 2024 · $40M seed
Jan 21, 2026 · $110M Series A
202 C Curative
$150M Dec 2, 2025 · $150M Series B+
—
203 A Alleviate
$150M Nov 4, 2025 · $150M Series B+
—
204 C Cognigy
$150M Nov 1, 2019 · $6M Series A
Jun 11, 2024 · $100M Series B+
205 C ClinChoice
$150M Jul 5, 2022 · $150M Series B+
—
206 H Honest Kitchen
$150M Apr 4, 2022 · $150M round
—
207 C Cardiac Dimensions
$149.2M Apr 16, 2014 · $20M Series A
Mar 20, 2025 · $53M Series B+
208 S Stanza Living
$146.19M Nov 28, 2017 · $2M seed
Oct 27, 2025 · $32.19M Series B+
209 S Stash Global
$146M May 12, 2025 · $146M Series B+
—
210 L Luma Health
$146M May 22, 2018 Series A
Nov 23, 2021 · $130M Series B+
211 S Suki Redwood City
$145M Mar 4, 2020 · $20M Series B+
Oct 13, 2026 Series B+
212 K Kinaset Therapeutics
$143M Nov 30, 2020 · $40M Series A
Jan 9, 2026 · $103M Series B+
213 L Lumafield
$142.5M Apr 13, 2022 · $32.5M seed
Mar 13, 2025 · $75M Series B+
214 N Nura Bio
$141.8M Sep 18, 2024 · $68M Series A
Jun 22, 2026 · $73.8M Series B+
215 A Augmedics
$141.8M Sep 19, 2017 · $8.3M Series A
Jul 4, 2023 · $82.5M Series B+
216 H Harbinger Health
$140M Sep 28, 2023 · $140M Series B+
Apr 14, 2026 round
217 H Honest Health
$140M Feb 26, 2026 · $140M round
—
218 I Impulse Dynamics
$140M Dec 1, 2019 · $80M Series B+
Dec 10, 2025 round
219 N Normunity
$140M Oct 25, 2022 · $65M Series A
Jan 13, 2025 · $75M Series B+
220 U UroMems
$139.67M Nov 15, 2016 · $15.07M Series A
May 13, 2026 · $60M round
221 E Endogenex
$138M Jun 25, 2024 · $88M Series B+
Mar 25, 2026 · $50M Series B+
222 C Class Technologies
$138M Sep 1, 2020 · $16M seed
Oct 7, 2023 seed
223 I Instawork
$138M May 22, 2019 · $18M Series B+
Jul 5, 2023 · $60M Series B+
224 E Endovascular Engineering
$137M Apr 6, 2022 · $15M Series A
Apr 7, 2026 · $80M Series B+
225 E EasyHealth
$135M Nov 18, 2021 · $135M Series A
—
226 E Eko Health
$133.8M Sep 17, 2014 · $800K seed
Jul 18, 2024 Series B+
227 A Angitia Bio
$130M Oct 19, 2023 Series B+
Feb 12, 2026 · $130M Series B+
228 S Solace Health
$130M Feb 10, 2026 · $130M Series B+
—
229 P Protego
$130M Dec 1, 2025 · $130M Series B+
—
230 B Big Health
$129.3M Apr 28, 2014 · $3.3M Series A
Jan 19, 2022 · $75M Series B+
231 L Lyka
$129M Nov 8, 2019 · $500K pre seed
Mar 3, 2026 · $67M Series B+
232 C Calibrate
$128M Jun 1, 2020 · $5M seed
Feb 3, 2024 Series B+
233 S Strata Oncology
$128M Jun 2, 2016 · $12M Series A
Jul 28, 2021 · $90M Series B+
234 K Kasa Living
$126M Dec 1, 2018 · $6M seed
Dec 11, 2023 Series B+
235 B Bright Peak Therapeutics
$125M Jul 28, 2020 · $35M Series A
Aug 17, 2026 Series B+
236 S SonoThera
$125M Jun 12, 2026 · $125M Series B+
—
237 C Collate
$125M Jan 13, 2025 · $30M seed
Jun 3, 2026 · $95M Series A
238 C Coultreon
$125M Apr 28, 2026 · $125M Series A
—
239 A Ambros Therapeutics
$125M Dec 16, 2025 · $125M Series A
—
240 E Everlab
$124M Dec 7, 2023 · $3M pre seed
Jul 30, 2026 seed
241 C Cartography Biosciences
$124M Jul 20, 2022 · $57M Series A
Oct 2, 2025 · $67M Series B+
242 P Personal Genome Diagnostics
$123.8M Mar 18, 2014 · $2.8M pre seed
Nov 24, 2025 Series B+
243 T Tasso
$123.1M Mar 5, 2019 · $6.1M Series A
Dec 16, 2021 · $100M Series B+
244 B Bolt Threads
$123M Jan 3, 2018 · $123M Series B+
Nov 3, 2024 Series B+
245 I IVX Health
$123M Aug 1, 2019 · $23M Series B+
Sep 21, 2021 · $100M Series B+
246 F FineHeart
$122.43M Mar 22, 2016 · $7.19M Series A
Jan 9, 2026 · $96.9M Series B+
247 A Ansa Biotechnologies
$122.4M Apr 11, 2022 · $68M Series A
Oct 1, 2025 · $54.4M Series B+
248 A Actio Biosciences
$121M Sep 1, 2023 · $55M Series A
Jun 18, 2025 · $66M Series B+
249 O Orbis Medicines
$121M Feb 1, 2024 · $28M seed
Jan 6, 2025 · $93M Series A
250 C Cellarity
$121M Oct 4, 2022 · $121M Series B+
Nov 26, 2024 Series B+